Ampio Pharmaceuticals, Inc.
(NYSE Amex Equities : AMPE)

( )
AMPE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
CTLTCatalent, Inc. -3.70%80.802.1%$222.46m
SAVACassava Sciences, Inc. -0.51%9.710.0%$169.20m
JAZZJazz Pharmaceuticals Plc -0.01%138.052.4%$166.39m
HZNPHorizon Therapeutics Plc -5.58%75.335.8%$155.15m
MRNSMarinus Pharmaceuticals, Inc. -10.91%10.707.8%$120.06m
CORTCorcept Therapeutics, Inc. -1.67%16.785.5%$117.65m
VRXValeant Pharmaceuticals International, Inc. -3.24%15.2314.1%$89.62m
BHCBausch Health Cos., Inc. -3.24%15.230.0%$60.32m
MYOKMyoKardia, Inc. 0.49%130.021.8%$58.56m
ARGXargenx SE -1.13%243.070.0%$54.10m
AMRNAmarin Corp. Plc -1.09%3.641.5%$53.67m
SAGESAGE Therapeutics, Inc. -1.83%58.908.6%$45.38m
GWPHGW Pharmaceuticals Plc -1.50%98.506.2%$41.18m
AXSMAxsome Therapeutics, Inc. -2.14%75.931.9%$38.49m
PRGOPerrigo Co. Plc -0.90%44.966.8%$36.50m

Company Profile

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.